Eli Lilly and Novo Nordisk are expected to announce deals with the Trump administration to cut prices of their weight-loss drugs in exchange for Medicare coverage, a White House source told Reuters on ...

A White House source says pharmaceutical companies Eli Lilly and Novo Nordisk are expected to announce deals soon with the ...

Lilly said the plant will strengthen its global supply chain and expand the capacity for its growing portfolio of oral ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

Eli Lilly raised its full-year profit and revenue forecasts on Thursday as strong appetite for its widely popular weight-loss ...

Eli Lilly raised its full-year profit and revenue forecast on Thursday, betting on surging demand for its blockbuster GLP-1 ...

Eli Lilly said on Wednesday it is partnering with Walmart to sell its weight-loss treatment Zepbound at the retailer's ...

Wegovy-maker Novo Nordisk lowered its full-year profit and sales forecast on Wednesday in an early blow to the Danish drugmaker's new CEO while it strives to claw back lost ground in a fierce obesity ...

Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss ...

Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their weight loss ...

Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss ...